05/08
Headlines

Northwest Biotherapeutics

Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Jason Knox02 mins

Inovio Pharmaceuticals, Inc. (AMEX:INO) entered into an office lease (the “Lease”) with a publicly owned real estate investment trust, located in Plymouth Meeting, Pennsylvania. We expect to occupy the space commencing in the third quarter of 2014. The initial term of the lease is eleven and one-half years. We intend to use the facility for…

Read More

Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)

John Meady02 mins

CRT Capital Thursday morning ratings report included a coverage initiation by analyst Arlinda Lee on Oncogenex Pharmaceuticals (NASDAQ: OGXI) with a Buy rating and price target of $20. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) rose 8.88 percent to $13.85 yesterday on volume of 483,342million shares. The intra-day range of the stock was $12.61 to $13.95. OncoGenex Pharmaceuticals…

Read More

Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

Richard Atkins02 mins

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at…

Read More

Pre-Market Noise Makers: Northwest Biotherapeutics (NASDAQ:NWBO), Children’s Place (NASDAQ:PLCE), Cooper Companies (NYSE:COO), Verisk Analytics (NASDAQ:VRSK)

John Meady02 mins

Shares in Northwest Biotherapeutics (NASDAQ:NWBO), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, have jumped 12% pre-market after the company said the Data Safety Monitoring Board has recommended its Phase III trial into a lethal form of brain cancer continue. The company’s lead program is a 312-patient Phase III trial in…

Read More

Hot News : Yahoo! Inc. (NASDAQ:YHOO), Ford Motor Co. (NYSE:F), Tesoro Logistics LP (NYSE:TLLP), Northwest Biotherapeutics, Inc. (NASDAQ:NWBO), AudioCodes Ltd. (NASDAQ:AUDC)

John Meady03 mins

Yahoo! Inc. (NASDAQ:YHOO) is making amends for years of blundering with one smart move: an early investment in China’s Alibaba Group that has turned into a multibillion-dollar boon. Yahoo! Inc. (NASDAQ:YHOO) belongs to Technology sector. Its net profit margin is 26.50% and weekly performance is 2.30%. On last trading day company shares ended up $42.08….

Read More

Why Need to Watch : Northwest Biotherapeutics (NASDAQ:NWBO), Akamai Technologies (NASDAQ:AKAM), Marathon Petroleum (NYSE:MPC), Learning Tree (NASDAQ:LTRE), Gramercy Property Trust (NYSE:GPT)

Colin Pettis03 mins

Northwest Biotherapeutics Inc. (NASDAQ:NWBO) (“NW Bio”) on 14 Aug 2014 announced the pricing of $17.5 million aggregate principal amount of its unsecured convertible notes (the “Notes”) in a private placement.The Notes are initially convertible at $7.30 per share a 10% premium above the closing market price of $6.64 per share on August 13 2014.NW Bio…

Read More